Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial (Q84342991)
Jump to navigation
Jump to search
scientific article published on 09 June 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial |
scientific article published on 09 June 2012 |
Statements
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial (English)
Baptist Gallwitz
Juan Guzman
Bruno Guerci
Rafael Simó
Bruce R Basson
Andreas Festa
Jacek Kiljański
Hélène Sapin
Michael Trautmann
Guntram Schernthaner